Key takeaways
- Approved peptide medicines are used for specific conditions written on their official label, such as osteoporosis or type 2 diabetes.
- Cosmetic peptides are tested on skin appearance in small trials, and are not reviewed by the FDA before sale.
- Research compounds such as BPC-157 and KPV have been studied mainly in rodents and cells; no use in people is established.
- The evidence behind a peptide belongs to that compound, in that form, in the model studied. It does not transfer by name.
01What are the three main uses of peptides?
In practice, peptides reach people through three routes, and each comes with its own standard of evidence. Peptides are a class of molecule, not a product: a peptide can be a hormone, a drug, a skin-care ingredient or a laboratory reagent.
Approved medicines have been through clinical trials and regulatory review. Cosmetic peptides have small skin-appearance studies and no pre-market review in the US. Research compounds are sold for laboratory use and have mostly been studied in animals and cells. If you are new to the term itself, start with what are peptides.
02At a glance: use, example, evidence
Each row names one compound and the strongest evidence behind the use listed. “Studied in” means researchers looked at it in that model, not that it does it in people.
| Approved use, or what was studied | Example | Evidence status |
|---|---|---|
| Starting or strengthening labour contractions; bleeding after birth | Oxytocin (Pitocin) | Approved prescription medicine (US label) |
| Central diabetes insipidus | Desmopressin (DDAVP) | Approved prescription medicine (US label) |
| Acromegaly, when surgery and other treatment are not enough | Octreotide (Sandostatin) | Approved prescription medicine (US label) |
| Osteoporosis at high risk of fracture | Teriparatide (Forteo) | Approved prescription medicine (US label) |
| Blood-sugar control in adults with type 2 diabetes | Semaglutide (Ozempic) | Approved prescription medicine (US label) |
| Appearance of facial fine lines (topical) | Palmitoyl pentapeptide (pal-KTTKS) | One randomised split-face trial, n=93, run by a company that sells skin-care products |
| Skin appearance (topical) | GHK-Cu (copper tripeptide) | Small topical human studies; injectable data is scarce |
| Tendon healing, studied in rats | BPC-157 | Rat studies; no published randomised trial in people |
| Gut inflammation, studied in mice and cells | KPV | Mouse colitis models and human cells in a dish |
| Skin and joints (marketed for) | Collagen peptides | Food supplement; see collagen vs research peptides |
03What are peptide medicines approved for?
When a regulator approves a peptide medicine, it approves specific uses, backed by the trials submitted. Those uses are printed on the label, and the label is public. Five examples, all from current US labels:
- Oxytocin is approved to start or strengthen contractions when there is a medical reason for delivery, and to control bleeding after birth. The label states it is not indicated for elective induction.
- Desmopressin, a synthetic analogue of the hormone vasopressin, is approved as antidiuretic replacement therapy in central diabetes insipidus.
- Octreotide, a cyclic eight-amino-acid peptide that mimics the hormone somatostatin, is approved to lower growth hormone and IGF-1 in acromegaly when surgery, radiation and other drugs have not worked or cannot be used.
- Teriparatide, the first 34 amino acids of the 84-amino-acid human parathyroid hormone, is approved for postmenopausal women with osteoporosis at high risk of fracture.
- Semaglutide is a prescription GLP-1 receptor agonist approved to improve blood-sugar control in adults with type 2 diabetes, among other labelled uses.
Insulin is left out of this list on purpose: at 51 amino acids it sits on the line between peptide and protein, and what are peptides explains why.
04What have cosmetic peptide studies measured?
Skin-care peptides are applied to the skin and tested on how the skin looks. In the US, the FDA does not approve cosmetics before they go on sale, and a product marketed to change the structure or function of the body is a drug under US law, or both a drug and a cosmetic. That is why cosmetic studies measure appearance.
The best-known example is a palmitoyl pentapeptide, pal-KTTKS. In a 2005 trial, 93 women aged 35 to 55 applied a moisturiser with the peptide to one side of the face and the same moisturiser without it to the other, for 12 weeks. The study was double-blind and randomised, and the outcome measured was wrinkles and fine lines in facial images. The researchers worked at Procter & Gamble, which sells skin-care products, and it is one trial.
GHK-Cu, a copper-binding tripeptide, is the other common example. The small human studies are of topical products; injectable data is scarce. Our GHK-Cu guide sets out what was studied and where the data stop.
05What have research peptides been studied in?
Research compounds are peptides that are not approved medicines and are sold labelled “research use only”. They have been studied in many models. Studied is the key word: the evidence sits mostly in animals and cells, and none of the uses below is established in people.
BPC-157
In a 2003 study, researchers cut the Achilles tendon in rats and measured how it healed with BPC-157 (animal model). Published human data is limited to small pilot studies and case reports, and no randomised controlled trial has been published. As of November 2026, none of the human studies registered on ClinicalTrials.gov has posted results. Detail: BPC-157 guide.
KPV
A three-amino-acid fragment of the hormone α-MSH. A 2008 study looked at it in two mouse models of colitis, given in drinking water, and in human intestinal and immune cells in a dish (animal and cell models).
The wider picture
A 2026 narrative review in Sports Medicine of 12 peptides marketed directly to patients reported that many of the unapproved ones have shown results in animal models, that rigorous human safety data are scarce, and that there is potential for serious harm to patients.
How each rung of evidence is weighed, from a cell study to a regulator’s approval, is on evidence grades. Whether these compounds can be sold, and to whom, depends on the country: see are peptides legal.
06What we don’t know
- Whether results from rodent and cell studies of research peptides carry over to people. For most of them, that has not been tested in a published controlled trial.
- What the registered BPC-157 trials will show. Until results are published, a registration is a plan, not evidence.
- How much the cosmetic findings depend on who ran the study. Many skin-care trials are small and run or funded by companies that sell the products.
- Whether a finding from one route applies to another. A cream study says nothing about an injection, and the reverse.
Educational content. Not medical advice.